Fabrizio Martora
Overview
Explore the profile of Fabrizio Martora including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
148
Citations
839
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Martora F, Battista T, Potestio L, Megna M
Dermatol Ther (Heidelb)
. 2025 Feb;
15(3):763-769.
PMID: 40016589
This article explores the ongoing research into the complex pathogenesis of hidradenitis suppurativa (HS) and the persistent challenges in finding effective treatments. With 113 clinical studies currently listed on ClinicalTrials.gov,...
2.
Potestio L, Martora F, Raia F, Lucagnano G, Brescia C, Torta G, et al.
Dermatol Ther (Heidelb)
. 2025 Feb;
15(3):721-731.
PMID: 39982649
Introduction: Bimekizumab and brodalumab are characterized by a different mechanism of action if compared to the other anti-interleukin (IL)-17s which target IL-17A. Indeed, brodalumab acts on IL-17RA whereas bimekizumab acts...
3.
Coronella L, Lauletta G, DE Lucia M, Martora F, Annunziata M
Ital J Dermatol Venerol
. 2025 Feb;
PMID: 39963733
No abstract available.
4.
5.
Martora F, Battista T, Giordano A, Potestio L, Megna M
Clin Cosmet Investig Dermatol
. 2025 Jan;
18():1-5.
PMID: 39802669
Hypergammaglobulinemia is a sign of B cell and plasma cell hyperactivity marked by elevated levels of gamma globulins, proteins within the gamma fraction of serum electrophoresis, linked to diseases like...
6.
Martora F, Battista T, Potestio L, Napolitano M, Patruno C, Megna M, et al.
Viruses
. 2025 Jan;
16(12.
PMID: 39772203
The COVID-19 pandemic has encouraged the rapid development and licensing of vaccines against SARS-CoV-2. Currently, numerous vaccines are available on a global scale and are based on different mechanisms of...
7.
Potestio L, Feo F, Martora F, Megna M, Napolitano M, DAgostino M
Clin Exp Dermatol
. 2024 Dec;
PMID: 39690824
Artificial Intelligence (AI) encompasses the development of computer systems capable of tasks typically requiring human intelligence, such as visual perception, speech recognition, decision-making, and language translation. Over time, numerous applications...
8.
Potestio L, Ruggiero A, Martora F, Megna M
Arch Dermatol Res
. 2024 Dec;
317(1):102.
PMID: 39666087
Bimekizumab, is the most recent monoclonal antibody licensed for the management of moderate-to-severe plaque psoriasis, acting through the dual inhibition of interleukin (IL)-17 A and IL17F, setting it apart from...
9.
Potestio L, Martora F, Villani A, Megna M
Clin Exp Dermatol
. 2024 Dec;
PMID: 39657712
No abstract available.
10.
Gargiulo L, Ibba L, Narcisi A, Giordano S, Maronese C, Martora F, et al.
Dermatol Pract Concept
. 2024 Dec;
14(4).
PMID: 39652961
Introduction: Psoriasis and hidradenitis suppurativa (HS) are chronic inflammatory diseases with significant overlap in their immunologic pathways, which involve cytokines such as tumor necrosis factor-alfa, interleukin (IL)-17, and IL-23. Current...